Home » Stocks » HCWB

HCW Biologics, Inc. (HCWB)

HCW Biologics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) 4.10M
Net Income (ttm) -7.74M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

HCW Biologics, Inc. has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About HCWB

HCW Biologics is an innovative clinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. We believe age-related low-grade chronic inflammation, or “inflammaging,” is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative disease, and autoimmune disease. Our gateway indication is oncology. By the en... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Pending
CEO
Hing C. Wong, Ph.D.
Employees
40
Stock Exchange
NASDAQ
Ticker Symbol
HCWB
Full Company Profile

Financial Performance

Financial Statements